Drug Pipeline for Dry Macular Degeneration

The following companies are developing drugs for treating Dry Macular Degeneration:

Acucela Inc., Alimera Sciences, Inc., Bioheart, Inc., Catalyst Biosciences, Inc.,

Cell Cure Neurosciences, Ltd., Eleven Biotherapeutics Inc., EyeCyte, Inc.,

Foamix Pharmaceuticals Ltd., Genentech, Inc., GlaxoSmithKline plc,

Icon Bioscience, Inc., Inotek Pharmaceuticals Corporation, MacuCLEAR, Inc.,

Neurotech Pharmaceuticals, Inc., Ocata Therapeutics, Inc., Ophthotech Corp.,

pSivida Corp., Tacere Therapeutics, Inc.

Contact them for more info.


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: